ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPRO CORPORATION
  3. Financials
  4. Property, plant and equipment, net

NIPRO CORPORATION (8086)

Market cap
¥281.7B
P/E ratio
20.7x
Nipro manufactures medical devices, generic pharmaceuticals, and pharma packaging materials, serving healthcare institutions with products like dialysis equipment, syringes, and glass vials.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndProperty, plant and equipment, net (Million JPY)YoY (%)
Mar 31, 2025503,827+4.64%
Mar 31, 2024481,508+11.32%
Mar 31, 2023432,550+14.51%
Mar 31, 2022377,752+12.46%
Mar 31, 2021335,906+9.22%
Mar 31, 2020307,551+8.11%
Mar 31, 2019284,483+5.26%
Mar 31, 2018270,273+10.67%
Mar 31, 2017244,222+9.15%
Mar 31, 2016223,756+1.62%
Mar 31, 2015220,195

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat